These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 29436675)
1. Combination of salinomycin and radiation effectively eliminates head and neck squamous cell carcinoma cells in vitro. Gehrke T; Hackenberg S; Polat B; Wohlleben G; Hagen R; Kleinsasser N; Scherzad A Oncol Rep; 2018 Apr; 39(4):1991-1998. PubMed ID: 29436675 [TBL] [Abstract][Full Text] [Related]
2. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt. Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396 [TBL] [Abstract][Full Text] [Related]
3. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells. Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495 [TBL] [Abstract][Full Text] [Related]
4. Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells. Zhu M; Chen S; Hua L; Zhang C; Chen M; Chen D; Dong Y; Zhang Y; Li M; Song X; Chen H; Zheng H Nanomedicine (Lond); 2017 Feb; 12(4):295-315. PubMed ID: 28093940 [TBL] [Abstract][Full Text] [Related]
5. HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress. Liu R; Zhang L; Yang J; Zhang X; Mikkelsen R; Song S; Zhou H PLoS One; 2015; 10(5):e0125928. PubMed ID: 25933118 [TBL] [Abstract][Full Text] [Related]
6. Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC). Moncharmont C; Guy JB; Wozny AS; Gilormini M; Battiston-Montagne P; Ardail D; Beuve M; Alphonse G; Simoëns X; Rancoule C; Rodriguez-Lafrasse C; Magné N Oncotarget; 2016 Jul; 7(30):47738-47749. PubMed ID: 27374096 [TBL] [Abstract][Full Text] [Related]
7. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts. Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020 [TBL] [Abstract][Full Text] [Related]
8. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells. Möckelmann N; Rieckmann T; Busch CJ; Becker B; Gleißner L; Hoffer K; Omniczynski M; Steinmeister L; Laban S; Grénman R; Petersen C; Rothkamm K; Dikomey E; Knecht R; Kriegs M Oncotarget; 2016 Apr; 7(17):23542-51. PubMed ID: 27015558 [TBL] [Abstract][Full Text] [Related]
9. Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro. Gehrke T; Scherzad A; Hackenberg S; Ickrath P; Schendzielorz P; Hagen R; Kleinsasser N Int J Oncol; 2017 Sep; 51(3):931-938. PubMed ID: 28713941 [TBL] [Abstract][Full Text] [Related]
10. Effects of salinomycin and CGP37157 on head and neck squamous cell carcinoma cell lines in vitro. Scherzed A; Hackenberg S; Froelich K; Rak K; Ginzkey C; Hagen R; Schendzielorz P; Kleinsasser N Mol Med Rep; 2015 Sep; 12(3):4455-4461. PubMed ID: 26099997 [TBL] [Abstract][Full Text] [Related]
11. Study on the sensitizing effect of SM-1 combined with irradiation on head and neck squamous cell carcinoma. Hu T; Liu GT; Wang DD; Xiao YT; Gou WF; Zuo DY; Hou WB; Li YL Int J Radiat Biol; 2024; 100(10):1453-1461. PubMed ID: 39136543 [TBL] [Abstract][Full Text] [Related]
12. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. De Schutter H; Kimpe M; Isebaert S; Nuyts S Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824 [TBL] [Abstract][Full Text] [Related]
13. 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226. Hehlgans S; Lange I; Eke I; Cordes N Radiother Oncol; 2009 Sep; 92(3):371-8. PubMed ID: 19729215 [TBL] [Abstract][Full Text] [Related]
14. Fenofibrate increases radiosensitivity in head and neck squamous cell carcinoma via inducing G2/M arrest and apoptosis. Liu J; Ge YY; Zhu HC; Yang X; Cai J; Zhang C; Lu J; Zhan LL; Qin Q; Yang Y; Yang YH; Zhang H; Chen XC; Liu ZM; Ma JX; Cheng HY; Sun XC Asian Pac J Cancer Prev; 2014; 15(16):6649-55. PubMed ID: 25169503 [TBL] [Abstract][Full Text] [Related]
15. Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition. Eke I; Dickreuter E; Cordes N Radiother Oncol; 2012 Aug; 104(2):235-42. PubMed ID: 22748391 [TBL] [Abstract][Full Text] [Related]
16. Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7). Pradier O; Rave-Fränk M; Schmidberger H; Bömecke M; Lehmann J; Meden H; Hess CF J Cancer Res Clin Oncol; 1999; 125(1):20-7. PubMed ID: 10037273 [TBL] [Abstract][Full Text] [Related]
17. AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo. Torres MA; Raju U; Molkentine D; Riesterer O; Milas L; Ang KK Invest New Drugs; 2011 Aug; 29(4):554-61. PubMed ID: 20119866 [TBL] [Abstract][Full Text] [Related]
18. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells. Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815 [TBL] [Abstract][Full Text] [Related]
19. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations. Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432 [TBL] [Abstract][Full Text] [Related]
20. Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer. Zerp SF; Stoter TR; Hoebers FJ; van den Brekel MW; Dubbelman R; Kuipers GK; Lafleur MV; Slotman BJ; Verheij M Radiat Oncol; 2015 Jul; 10():158. PubMed ID: 26223311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]